Law Firm Withdraws Bid to Block Challenges to Blue Cross Blue Shield Settlement

Plaintiffs’ attorneys who secured a $2.8 billion antitrust settlement against Blue Cross Blue Shield have withdrawn their attempt to prevent a Washington, D.C., law firm from advising hospitals to reject the deal and pursue individual lawsuits, according to Reuters.
In a court filing submitted in Alabama on Thursday, the plaintiffs’ firm Whatley Kallas and several other legal teams announced they would no longer seek to bar Zuckerman Spaeder from representing hospitals that might opt out of the class-action settlement. Per Reuters, the filing noted that the parties had reached an agreement, though the terms were not disclosed.
Hospitals and other healthcare providers have until March 4 to decide whether to participate in the settlement, which received preliminary approval in December. The agreement seeks to resolve claims that Blue Cross Blue Shield underpaid healthcare providers for reimbursements.
On Friday, Chief U.S. District Judge R. David Proctor in Birmingham granted the request to drop the disqualification bid, Reuters reported. Whatley Kallas had previously accused Zuckerman of improperly using confidential information from related litigation against Blue Cross to attract clients. Zuckerman Spaeder denied these allegations.
Read more: Attorneys Seek Major Payout in Blue Cross Antitrust Case
Zuckerman is among several firms that pursued antitrust claims against Blue Cross and its affiliates, alleging they conspired to limit competition and overcharge subscribers. The U.S. Supreme Court upheld a separate $2.7 billion settlement last year in a related case. Blue Cross has denied any wrongdoing in agreeing to settle both lawsuits.
Class-action settlements often include provisions allowing defendants to withdraw from an agreement if a significant number of potential plaintiffs opt out in favor of individual lawsuits. According to Reuters, Whatley Kallas stated that its motion to disqualify Zuckerman was not influenced by any opt-out provisions in the settlement.
“As class counsel we want to make sure that the decisions of class members are made based on full and complete information, coming from lawyers who are not conflicted,” the firm previously told Reuters.
The case, formally titled In re: Blue Cross Blue Shield Antitrust Litigation, is being heard in the U.S. District Court for the Northern District of Alabama under case number 2:13-cv-20000-RDP.
Source: Reuters
Featured News
House Judiciary Committee Examines Antitrust Issues in Medical Residency Market
Mar 17, 2025 by
CPI
Belgian Competition Authority Accuses Roche of Anticompetitive Practices in Cancer Drug Market
Mar 17, 2025 by
CPI
PepsiCo to Acquire Prebiotic Soda Brand Poppi for $1.95 Billion
Mar 17, 2025 by
CPI
Tech Companies Face Tightened Online Safety Rules in the UK, Starting Monday
Mar 17, 2025 by
CPI
UK Government to Tighten Merger Scrutiny in New Plan by Chancellor Reeves
Mar 17, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Self-Preferencing
Feb 26, 2025 by
CPI
Platform Self-Preferencing: Focusing the Policy Debate
Feb 26, 2025 by
Michael Katz
Weaponized Opacity: Self-Preferencing in Digital Audience Measurement
Feb 26, 2025 by
Thomas Hoppner & Philipp Westerhoff
Self-Preferencing: An Economic Literature-Based Assessment Advocating a Case-By-Case Approach and Compliance Requirements
Feb 26, 2025 by
Patrice Bougette & Frederic Marty
Self-Preferencing in Adjacent Markets
Feb 26, 2025 by
Muxin Li